SCI Pharmtech Inc., founded by Switzerland-based Siegfried Ltd. in 1987, is now a public company listed at Taiwan Stock Exchange. Since 1989, SCI has satisfied worldwide customers with quality and cost-effective APIs, advanced intermediates, and custom products. Our fully equipped research laboratories, pilot and production plants and experienced staff ensure timely development and cost effective production. We work with pharmaceutical and specialty companies worldwide to develop key intermediates, APIs and custom products. Our facility is FDA,EDQM, PMDA, MFDS and Taiwan TFDA inspected, designed for multi-purpose, full-scale manufacturing."